Search

Author/Creator Hojnik, Maja

2. Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y). Issue 8 (6th May 2021)

Authors:
Landewé, Robert BM; Gensler, Lianne S; Poddubnyy, Denis; Rahman, Proton; Hojnik, Maja; Li, Xiaoqi; Liu Leage, Soyi; Adams, David; Carlier, Hilde; Van den Bosch, Filip
Other Names:
author non-byline.; Ariel Federico Javier author non-byline.; Berman Alberto author non-byline.; Carrio Judith author non-byline.; Lucero Eleonora Del Valle author non-byline.; Cocco Jose Maldonado author non-byline.; Velasco Benito Jorge author non-byline.; Resch Heinrich author non-byline.; Gr...
Journal:
Annals of the rheumatic diseases
Issue:
Volume 80:Issue 8(2021)
Page Start:
1022
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Design of a phase IV randomised, double-blind, placebo-controlled trial assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) patients (PREDICTRA). Issue 2 (28th February 2018)

Authors:
Emery, Paul; Burmester, Gerd R; Naredo, Esperanza; Zhou, Yijie; Hojnik, Maja; Conaghan, Philip G
Journal:
BMJ open
Issue:
Volume 8:Issue 2(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis. (September 2022)

Authors:
Maksymowych, Walter P; Baraliakos, Xenofon; Lambert, Robert G; Landewé, Robert; Sandoval, David; Carlier, Hilde; Lisse, Jeffrey; Li, Xiaoqi; Hojnik, Maja; Østergaard, Mikkel
Journal:
Lancet
Issue:
Volume 4:Number 9(2022)
Page Start:
e626
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial. Issue 10217 (4th January 2020)

Authors:
Deodhar, Atul; van der Heijde, Désirée; Gensler, Lianne S; Kim, Tae-Hwan; Maksymowych, Walter P; Østergaard, Mikkel; Poddubnyy, Denis; Marzo-Ortega, Helena; Bessette, Louis; Tomita, Tetsuya; Leung, Ann; Hojnik, Maja; Gallo, Gaia; Li, Xiaoqi; Adams, David; Carlier, Hilde; Sieper, Joachim
Journal:
Lancet
Issue:
Volume 395:Issue 10217(2019)
Page Start:
53
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naïve to biological disease-modifying antirheumatic drug: final results by week 52. Issue 10 (13th July 2020)

Authors:
Smolen, Josef S; Mease, Philip; Tahir, Hasan; Schulze-Koops, Hendrik; de la Torre, Inmaculada; Li, Lingnan; Hojnik, Maja; Sapin, Christophe; Okada, Masato; Caporali, Roberto; Gratacós, Jordi; Goupille, Philippe; Liu Leage, Soyi; Pillai, Sreekumar; Nash, Peter
Journal:
Annals of the rheumatic diseases
Issue:
Volume 79:Issue 10(2020)
Page Start:
1310
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. P261 Continuing versus withdrawing ixekizumab in patients with PsA who achieved sustained minimal disease activity: results from the SPIRIT-P3 study. (20th April 2020)

Authors:
Coates, Laura C; Pillai, Sreekumar G; Zhang, Lu; Adams, David; Kerr, Lisa; Hojnik, Maja; Gallo, Gaia; Valter, Ivo; Tahir, Hasan; Chandran, Vinod; Mease, Philip; Kavanaugh, Arthur
Journal:
Rheumatology
Issue:
Volume 59(2020)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗